The episode-free day as a composite measure of effectiveness: an illustrative economic evaluation of formoterol versus salbutamol in asthma therapy.
about
Surveillance for isocyanate asthma: a model based cost effectiveness analysisRegular treatment with formoterol for chronic asthma: serious adverse eventsRegular treatment with formoterol for chronic asthma: serious adverse eventsOutcome measurement in economic evaluations of public health interventions: a role for the capability approach?The limited incorporation of economic analyses in clinical practice guidelines.A systematic review of economic evaluations of therapy in asthmaEvaluating preference weights for the Asthma Symptom Utility Index (ASUI) across countries.Pharmacoeconomics of asthma treatment.Effect of montelukast added to inhaled budesonide on control of mild to moderate asthmaModelling the 5-year cost effectiveness of tiotropium, salmeterol and ipratropium for the treatment of chronic obstructive pulmonary disease in Spain.Endometrial ablation for heavy menstrual bleeding.Economic burden of asthma: implications for outcomes and cost-effectiveness analyses.National Asthma Education and Prevention Program working group report on the cost effectiveness of asthma care.Patient weighting of importance of asthma symptoms.An evaluation of patients' willingness to trade symptom-free days for asthma-related treatment risks: a discrete choice experiment.Cost-effectiveness analysis of formoterol versus salmeterol in patients with asthma.
P2860
Q23911463-D28F24B4-97C8-45A9-8760-7EC4DF0AB512Q24200353-8CA9B7D1-A459-4CD2-950C-11E8F79C98F2Q24241250-ADC5E63C-685C-4023-BFDE-3786824BE410Q33965860-DA7CC121-30AA-4D45-A4E2-E5E0160FFDA8Q34585520-35E77B38-C30B-4DD8-9135-466BC20E88AFQ34620146-2BEC8243-0E13-4521-8771-75FFE022FC7BQ35017303-6E2A35AA-89E1-4A09-8D33-CFFD3CD6F7E7Q35076572-F80C211B-8EA9-40D8-961B-5CCFF5733381Q35535801-47141B7D-CD3C-4CE1-89EC-ACC5556FFA39Q35878722-4BA1A419-C3D1-4299-9321-CF95A7D365E6Q35891545-02C34E21-86C0-4BC5-AB57-8A7FCE233C71Q40674182-B3E8978F-EB7B-440D-B930-0F045FF22D01Q41114417-3D35DE14-9FC8-43C7-8C89-308AD2F126D4Q41937335-2DE50A71-AAA7-4C83-9A1D-6490ACF82CECQ51124455-AFA20721-A1FF-49E1-B67B-B0E4B8DDD805Q53931563-F94EACEC-D3DF-47FD-9AEF-52B090335187
P2860
The episode-free day as a composite measure of effectiveness: an illustrative economic evaluation of formoterol versus salbutamol in asthma therapy.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh-hant
name
The episode-free day as a comp ...... salbutamol in asthma therapy.
@en
The episode-free day as a comp ...... salbutamol in asthma therapy.
@nl
type
label
The episode-free day as a comp ...... salbutamol in asthma therapy.
@en
The episode-free day as a comp ...... salbutamol in asthma therapy.
@nl
prefLabel
The episode-free day as a comp ...... salbutamol in asthma therapy.
@en
The episode-free day as a comp ...... salbutamol in asthma therapy.
@nl
P1433
P1476
The episode-free day as a comp ...... salbutamol in asthma therapy.
@en
P2093
M J Buxton
M J Sculpher
P304
P356
10.2165/00019053-199304050-00005
P577
1993-11-01T00:00:00Z
P6179
1011584284